Cochlear share price tumbles on broker downgrade

The Cochlear Limited (ASX:COH) share price is tumbling lower on Friday after being downgraded by Goldman Sachs…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cochlear Limited (ASX: COH) share price is ending the week with a day deep in the red.

In afternoon trade the hearing solutions company's shares are down 4.5% to $231.30.

a woman

Why is the Cochlear share price sinking lower today?

The catalyst for today's decline appears to be a broker note out of Goldman Sachs this morning.

According to the note, the broker has downgraded Cochlear's shares to a sell rating with a $214.00 price target.

This price target implies potential downside of 7.5% over the next 12 months.

Why did Goldman Sachs downgrade Cochlear's shares?

According to the note, Goldman Sachs made the move largely on valuation grounds after a strong share price gain over the last 12 months.

And whilst it is a fan of the company and its competitive position in an attractive market, it appears concerned that its growth could underwhelm over the coming years and fail to justify the premium its shares trade at.

The broker explained: "Whilst it is competitively positioned in a generally attractive market, we have long argued that COH faces a number of challenges in delivering consistently high growth on a base which effectively starts from new each year. In our view, 1H20 provided the clearest evidence yet that the mid/long-term market trajectory is materially slower than current market expectations."

"There are still many reasons to like this stock, but shares have climbed +36% over the last 12m (vs. market +18%) despite mounting evidence that long-debated challenges are coming to bear. We believe COH's EBIT CAGR of 7% (FY19-22E) no longer supports its peak multiple (30x NTM EBITDA, +2SDs above 5yr avg.; +27% vs. sector)," the broker added:

What challenges does Cochlear face?

Goldman Sachs is concerned that the incremental growth opportunity has increasingly shifted from children to adults.

Whilst the volume upside in adults is significantly larger, the broker believes the challenges of reaching the adult segment outweigh the additional penetration upside from that opportunity.

In light of this, it feels delivering consistently high growth on an installed base which effectively starts from new each year is a substantial task.

Goldman Sachs is more positive on Lifestyle Communities Limited (ASX: LIC) and Origin Energy Ltd (ASX: ORG). This week it retained its conviction buy ratings on both of their shares.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wonderful day on the markets.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Up 155% since April, is it too late to buy Megaport shares today?

A leading analyst delivers his forecast for Megaport’s outperforming shares.

Read more »

Inflation written on a coffee mug with coins in it.
ASX Share Market News

Buying ASX 200 shares? Here's what the June inflation print means for RBA interest rates

Will ASX investors get an interest rate reprieve from the RBA following the latest inflation figures?

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Macquarie tips these 3 ASX stocks to return better than 45%

Recent updates have the broker optimistic about these companies.

Read more »

Many cars travel on a busy six lane road way with other cars in the background travelling in the opposite direction.
ASX Share Market News

Atlas Arteria Q2 2026 earnings: Stable toll revenues, new debt facility boosts liquidity

Atlas Arteria posts flat Q2 toll revenues and boosts liquidity with a new A$150 million corporate loan.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Leading broker on DroneShield shares and rising competition 

Bell Potter has been running the rule over this popular stock.

Read more »

Rival hands reaching upward for a company trophy or prize.
Opinions

Up 214% in 5 years! Is this still a top Australian stock to buy?

This business has done extremely well. Is it still a buy?

Read more »

A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
Broker Notes

Why Morgans rates these ASX shares as buys this week

Fresh company updates have given Morgans three very different reasons to remain bullish.

Read more »